Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML)

By Kang H.J.   Shin H.Y.   Choi H.S.   Ahn H.S.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 167-170

Elsevier

Access to resources Recommend Favorite

Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy

By Fukushima Hiroko  

International Journal of Hematology, Vol. 95, Iss. 5, 2012-05 ,pp. : 581-584

Springer Publishing Company

Access to resources Recommend Favorite

Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation

By Raepple D.  

Annals of Hematology, Vol. 88, Iss. 4, 2009-04 ,pp. : 319-324

Springer Publishing Company

Access to resources Recommend Favorite

Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo

By Ramshaw H.S.   Bardy P.G.   Lee M.A.   Lopez A.F.  

Experimental Hematology, Vol. 30, Iss. 10, 2002-10 ,pp. : 1124-1131

Elsevier

Access to resources Recommend Favorite

p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)

By Dai Hai-ping  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 814-817

Springer Publishing Company

Access to resources Recommend Favorite